(Q44151669)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Clinical management of HCV carriers with normal aminotransferase levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Daniele Prati

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

C Puoti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Guido

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Mangia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Committee on HCV carriers with normal alanine aminotransferase levels of the Italian Association for the Study of the Liver

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

Digestive and Liver Disease

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

362-369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

Updated definitions of healthy ranges for serum alanine aminotransferase levels

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC).

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Detection of plus and minus HCV RNA in normal liver of anti-HCV-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Persistent hepatitis C viraemia without liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

A retrospective study of hepatitis C virus carriers in a local endemic town in Japan. A possible presence of asymptomatic carrier

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Follow up of blood donors positive for antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV-positive chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Do symptomless HCV carriers spread infection to their relatives?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Lack of association between type of hepatitis C virus, serum load and severity of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2803%2900185-3

7 January 2021

10.1016/S1590-8658(03)00185-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12846410%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference